T0	Outcomes 809 939	overall survival (OS), distant metastasis-free survival (DMFS), local relapse-free survival (LRFS), or disease-free survival (DFS;
T1	Outcomes 1140 1180	The 5-year OS, DMFS, LRFS, and DFS rates